Cancer research communications 4(2) 446-459 2024年2月
UNLABELLED: Invariant natural killer T (iNKT) cells play an essential role in antitumor immunity by exerting cytotoxicity and producing massive amounts of cytokines. iNKT cells express invariant T-cell receptors (TCR) to recognize their cognate gl...
Antibody-mediated rejection (AMR) is a risk factor for chronic lung allograft dysfunction, which impedes long-term survival after lung transplantation. There are no reports evaluating the efficacy of the single use of anti-CD20 antibodies (aCD20s)...
Ryo Koyama-Nasu   Motoko Y Kimura   Masahiro Kiuchi   Ami Aoki   Yangsong Wang   Yukiyoshi Mita   Ichita Hasegawa   Yukihiro Endo   Atsushi Onodera   Kiyoshi Hirahara   Shinichiro Motohashi   Toshinori Nakayama   
Cancer immunology research 2023年5月 [査読有り]
Tumor-specific CD8+ T cells play a pivotal role in anti-tumor immunity and are a key target of immunotherapeutic approaches. Intratumoral CD8+ T cells are heterogeneous; Tcf1+ stem-like CD8+ T cells give rise to their cytotoxic progeny - Tim-3+ te...
Inflammation and regeneration 43(1) 27-27 2023年5月 [査読有り]
Invariant natural killer T (iNKT) cells are a subset of innate-like T cells restricted by a major histocompatibility complex (MHC) class I-like molecule, CD1d. iNKT cells express an invariant T cell receptor (TCR) encoded by Vα14 Jα18 in mice and ...
Hara, A   Nasu, R   Takami, M   Hirono, S   Matsutani, T   Nakayama, T   Iwadate, Y   Motohashi, S   
Hara, A   Nasu, R   Takami, M   Hirono, S   Matsutani, T   Nakayama, T   Iwadate, Y   Motohashi, S   
Aoki, T   Takami, M   Takatani, T   Motoyoshi, K   Ishii, A   Hara, A   Hino, M   Shimojo, N   Motohashi, S   
Yoshizawa, H   Harada, K   Ishii, A   Mise, N   Hishiki, T   Saito, K   Nakata, M   Komatsu, S   Nakayama, T   Yoshida, H   Takami,M   Motohashi, S